May 2012 FDA Recall Drug by Bayer Healthcare Pharmaceuticals Inc.
D-1433-2012 - Cross Contamination w/Other Products

This Class II drug recall was voluntarily initiated by Bayer Healthcare Pharmaceuticals Inc. on May 8, 2012 for the product Drug. The FDA reported the reason for recall as cross contamination w/other products. The product was distributed in Kansas and California. and the recall is currently terminated.

Recall Number: D-1433-2012

Reason for Recall
Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.
Initiated
05-08-2012
Reported
08-08-2012
Quantity
112.295 kg

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Bayer HealthCare Pharmaceuticals Inc.
Kansas and California.
Estradiol Hemihydrate M20 EP/USP Powder, packaged in a) 1.5 kg and b) 2.5 kg fiber drums, Rx only, Art. No. 165811, Bayer Pharma AG, D-13342 Berlin.

Batch or Lot Expiration Information

Lot# Lot Number: 81202450, Exp 06/15/16